Joseph S Zakrzewski insider trades

Open-market stock purchases and sales by Joseph S Zakrzewski, Unknown at AN2 Therapeutics, Inc, from SEC Form 4 filings since Jun 1, 2010.

Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +244%.

Recent trades

DateStockTradeValue
Mar 19, 2026ANTX AN2 Therapeutics, IncBought (not open market)$391K
Mar 19, 2026ANTX AN2 Therapeutics, IncSold (not open market)$660K
Mar 19, 2026ANTX AN2 Therapeutics, IncBought (not open market)$40.5K
Mar 19, 2026ANTX AN2 Therapeutics, IncSold (not open market)$179K
Mar 19, 2026ANTX AN2 Therapeutics, IncBought (not open market)$92.8K
Mar 19, 2026ANTX AN2 Therapeutics, IncSold (not open market)$140K
Feb 20, 2026ANTX AN2 Therapeutics, IncBought (not open market)—

Companies traded

  • ANTX AN2 Therapeutics, Inc: 3 buys, 1 sale, last Mar 19, 2026
  • CYT Cyteir Therapeutics, Inc: 11 buys, last Feb 6, 2024
  • SGMO Sangamo Therapeutics, Inc: 3 buys, last Feb 25, 2022
  • AMRN Amarin Corp Plc\uk: 3 buys, 20 sales, last Dec 15, 2021
  • XLRN Acceleron Pharma Inc: 2 buys, 7 sales, last Nov 19, 2021
  • PODD Insulet Corp: 5 sales, last May 17, 2017
  • LPDX Liposcience Inc: other filings, last Nov 20, 2014

Get free alerts when Joseph S Zakrzewski files a new trade →